Announced Mon, 25 May · 20:13 IST

Change In Management - appointment of Dr. Swetha as Additional Director, appointment of Internal Auditor and Resignation of Mr. Baskaran as Director

Promoter Family Board EntryManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹78.89
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.5-8.4-12.9-17.3-21.4-25.6-19.5-27.5-33.9
Up moveDown movePending
AI summary

The Board meeting on 25 May 2026 approved three key changes: (1) Appointment of Dr. Swetha as Additional Director (Non-Executive, Non-Independent) effective from 25 May 2026, subject to shareholder approval. Dr. Swetha, who holds an MBBS, MBA and PhD, is a renowned industrialist heading the Accord Group and Bharath Group of Institutions spanning healthcare, education, hospitality, pharma and infrastructure. She is related to Mr. Sundeep Anand Jegath Rekshagan, a Promoter of the Company, though not related to any existing directors. (2) Re-appointment of M/s. B. Thiagarajan & Co., Chartered Accountants as Internal Auditor for two years (FY 2026-27 & FY 2027-28). (3) Resignation of Mr. S Baskaran as Non-Executive Director effective 25 May 2026, citing preoccupation and personal commitments. He confirmed no material reason other than stated.

Likely market impact

The appointment of a promoter-connected director (Dr. Swetha) signals potential family succession or consolidation of promoter control on the board, which could be viewed positively by some investors but raises governance considerations for others. The resignation of Mr. Baskaran, while citing personal reasons, leaves a board seat pending shareholder confirmation of the new appointment.